Armistice Capital, LLC Exact Sciences Corp Transaction History
Armistice Capital, LLC
- $6.56 Billion
- Q1 2025
A detailed history of Armistice Capital, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Armistice Capital, LLC holds 1,772,369 shares of EXAS stock, worth $73.4 Million. This represents 1.17% of its overall portfolio holdings.
Number of Shares
1,772,369
Previous 1,617,000
9.61%
Holding current value
$73.4 Million
Previous $90.9 Million
15.56%
% of portfolio
1.17%
Previous 1.28%
Shares
12 transactions
Others Institutions Holding EXAS
# of Institutions
642Shares Held
160MCall Options Held
1.69MPut Options Held
1.42M-
Capital World Investors Los Angeles, CA18.2MShares$754 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$742 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$518 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$500 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$274 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.33B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...